Parviz Azimnasab-Sorkhabi

5PUBLICATIONS
2CO-AUTHORS
Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Neurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 22, 2023
Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.

Parviz Azimnasab-Sorkhabi, Maryam Soltani-Asl, Túlio Teruo Yoshinaga

|Apr 04, 2023
IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells.

Parviz Azimnasab-Sorkhabi, Maryam Soltani-Asl, Túlio Teruo Yoshinaga

|Mar 13, 2023
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells.

Parviz Azimnasab-Sorkhabi, Maryam Soltani-Asl, Jose Roberto Kfoury Junior

|Oct 11, 2022
The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran.

Parviz Azimnasab-Sorkhabi, Maryam Soltani-Asl, José Roberto Kfoury

Pageof 1